Navigation Links
New paper offers breakthrough on blinking molecules phenomenon
Date:8/11/2010

A new paper by University of Notre Dame physicist Boldizsr Jank and colleagues offers an important new understanding of an enduring mystery in chemical physics.

More than a century ago, at the dawn of modern quantum mechanics, the Noble Prize-winning physicist Neils Bohr predicted so-called "quantum jumps." He predicted that these jumps would be due to electrons making transitions between discrete energy levels of individual atoms and molecules. Although controversial in Bohr's time, such quantum jumps were experimentally observed, and his prediction verified, in the 1980s. More recently, with the development of single molecule imaging techniques in the early 1990s, it has been possible to observe similar jumps in individual molecules.

Experimentally, these quantum jumps translate to discrete interruptions of the continuous emission from single molecules, revealing a phenomenon known as fluorescent intermittency or "blinking."

However, while certain instances of blinking can be directly ascribed to Bohr's original quantum jumps, many more cases exist where the observed fluorescence intermittency does not follow his predictions. Specifically, in systems as diverse as fluorescent proteins, single molecules and light harvesting complexes, single organic fluorophores, and, most recently, individual inorganic nanostructures, clear deviations from Bohr's predictions occur.

As a consequence, virtually all known fluorophores, including fluorescent quantum dots, rods and wires, exhibit unexplainable episodes of intermittent blinking in their emission.

The prevailing wisdom in the field of quantum mechanics was that the on and off blinking episodes were not correlated. However, at a 2007 conference on the phenomenon sponsored by Notre Dame's Institute for Theoretical Sciences, which Jank directs, Fernando Stefani of the University of Buenos Aires presented research suggesting that there was, in fact, correlation between these on and off events. No theoretical model available at that time was able to explain these correlations.

In a 2008 Nature Physics paper, Jank and a group of researchers that included Notre Dame chemistry professor Ken Kuno, physics visiting assistant professor Pavel Frantsuzov and Nobel Laureate Rudolph Marcus suggested that the on- and off-time intervals of intermittent nanocrystal quantum dots follow universal power law distributions. The discovery provided Jank and other researchers in the field with the first hints for developing a deeper insight into the physical mechanism behind the vast range of on- and off-times in the intermittency.

In a new paper appearing in the journal Nano Letters, Jank, Frantsuzov and Notre Dame graduate student Sndor Volkn-Kasc reveal that they have developed a model for the blinking phenomena that confirms what Stefani observed experimentally. The finding is important confirmation that strong correlation exists between the on and off phenomenon.

If the blinking process could be controlled, quantum dots could, for example, provide better, more stable imaging of cancer cells; provide researcher with real-time images of a viral infection, such as HIV, within a cell; lead to the development of a new generation of brighter display screens for computers, cell phones and other electronic applications; and even improved lighting fixtures for homes and offices.

The Nano Letters paper represents another important step in understanding the origins of the blinking phenomenon and identifying ways to control the process.


'/>"/>

Contact: Boldizsar Janko
jano.2@nd.edu
574-850-9850
University of Notre Dame
Source:Eurekalert

Related biology technology :

1. Live Webinar: Lonza's Paperless EM Success and Acquisition of MODA
2. Webinar Alert: Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance
3. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
4. Berkeley Lab scientists create molecular paper
5. 'Cancer Research' Has Published a Paper on the Activity of MM-121, an ErbB3 Inhibitor, in Ligand-dependent Tumors
6. Nanotechnology sparks energy storage on paper and cloth
7. Adaptive Trial Paper Explores Benefits of Adaptive Trials for Phase I, Phase II Studies
8. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
9. Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery
10. Free Organic Electronics White Paper Discusses Rfid Tags, OLED, AM OLED, PM OLED, Electroluminescence, e-Paper, OE Market Forecast
11. PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... RICHLAND, Wash., Feb. 10, 2016  IsoRay, Inc. (NYSE ... seed brachytherapy and medical radioisotope applications for the treatment ... cancers, today announced its financial results for the second ... December 31, 2015. --> ... second quarter of fiscal 2016, which ended December 31, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... 2016 , ... Curoverse announced today that the open-source, multi-platform ... for managing and processing genomic and health data at petabyte scale. ... analyzing genomic data,” said Adam Berrey chief executive officer at Curoverse. “Microsoft Azure ...
(Date:2/9/2016)... ... 09, 2016 , ... With a presidential election in November and the future ... bring together over 500 top healthcare leaders for a night and day of debates ... by MBA students of the University of Pennsylvania’s Wharton School, will be held February ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first day ... announced plans to develop a first of its kind ... of IBM Watson. In the first application of ... (NYSE: IBM ), and Welltok will create a ... assessments with cognitive analytics, delivered on Welltok,s health optimization ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):